Possibilities of Using Nootropic Drugs to Reduce Neurotoxic Reactions Caused by Anti-tuberculosis Drugs in Experimental Conditions-Reference-Cited by-同舟云学术

Possibilities of Using Nootropic Drugs to Reduce Neurotoxic Reactions Caused by Anti-tuberculosis Drugs in Experimental Conditions

Published:2024-07-04 Issue:3 Volume:102 Page:6-11
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Mozhokina G. N.¹^ORCID,Samoylova A. G.¹^ORCID,Vasilyeva I. A.¹^ORCID

Affiliation:

1. National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health

Abstract

The objective: to evaluate the neuroprotective activity of cytoflavin and combinations of mexidol with vitamin B6 or Magne B6 by changes in behavioral reactions in rats during in-take of a neurotoxic combination of anti-tuberculosis drugs.Subjects and Methods. Non-linear female rats divided in 4 groups were used in this study. For 14 days, all rats received a combination of Mxf+Lzd+Cs+Pto daily. Additionally, rats of Group 2 were administered cytoflavin before administration of the basic combination; Group 3 – Mexidol + vitamin B6; Group 4 - Mexidol + Magne B6. Doses of anti-tuberculosis drugs, cytoflavin, Mexidol, vitamin B6 and Magne B6 correspond to the recommended doses for humans. The manifestation of neurotoxicity was assessed by changes in behavioral reactions by Open Field Test.Results. Neurotoxicity caused by the combination Mxf+Lzd+Cs+Pto was manifested by a decrease in motor activity, exploratory activity and grooming. With cytoflavin administration, all parameters of behavioral reactions in rats improved. When using Mexidol with vitamin B6, only a slight decrease in grooming versus the baseline level was observed. There was a less qualitative decrease in neurotoxicity manifestations with administration of Mexidol in combination with Magne B6.

Publisher

LLC "Medical Knowledge and Technologies"

Reference18 articles.

1. Belov V.G., Parfenov Yu.A., Okovity S.V. Therapy of alcohol dependence syndrome using cytoflavin. Journal Nevrologii i Psikhiatrii, 2013, 6, issue 2, pp. 47-50. (In Russ.)

2. Vasiliev S.A. Neyrometabolicheskaya terapiya ostrykh tyazholykh otravleniy v tom chisle pri ostroy alkogolnoy intoksikatsii v sostave detoksikatsionno-infuzio nnoyterapii. Avtoref. diss. dokt. med. nauk. [Neurometabolic therapy of acute severe poisoning including acute alcohol intoxication as part of detoxification and infusion therapy. Sinopsis of Doct. Diss.]. St. Petersburg, 2008.

3. Golovko A.I., Batotsyrenova E.G., Komov Yu.V., Khalchitskiy S.E., Kashuro V.A. Review of drugs for the correction of central nervous system disorders that have developed as a result of the action of neurotoxicants. Farmakologiya, 2022, vol. 23, pp. 385. (In Russ.)

4. Gromova O.A., Torshin I.Yu., Kalacheva A.G. et al. Triple synergism of ethylmethylhydroxypyridine succinate, magnesium and vitamin B6: molecular mechanisms. Nevrologiya, Neyropsikhiatriya, Psikhosomatika, 2017, vol. 9, no. 1, pp. 42-49. (In Russ.)

5. Gromova O.A., Torshin I.Yu., Limanova O.A., Fedotova L.E., Kalacheva A.G., Grishina T.R. Antibiotic therapy provokes magnesium deficiency. What to do? Pharmateka, 2016, no. 14, pp. 6-13. (In Russ.)